Regor Therapeutics is an international biotech company that focuses in the therapeutic areas of oncology, metabolic and autoimmune diseases. Founded by Min Zhong, Wenge Zhong, Xiaotian Zhu, and Xiayang Qiu in 2018, Regor Therapeutics is backed by Lilly Asia Ventures, Eli Lilly, Loyal Valley Capital, TF Capital, and Qilu Pharmaceutical and is headquartered in Boston.